New Drug Notices
This page illustrates Lexicomp's commitment to its publishing model. Our online and handheld drug databases are updated daily, providing timely information on medications and vital healthcare topics.
Below is a list of new drug approvals and new combination monographs that have been added to Lexicomp's core drug database within the last 12 months.
View Complete Monographs
New drug monographs are available immediately to subscribers of Lexicomp Online, and Lexicomp On-Hand, our handheld software.
View an example of a monograph in Lexicomp Online.
New Drug Approvals
Generic
Brand
Pharmacologic Category
January 2012
Ivacaftor
Kalydeco
Cystic Fibrosis TCRP
Vismodegib
Erivedge
Antineoplastic, Hedgehog Pathway Inhibitor
Axitinib
Inlyta
Antineoplastic Agent, VEGF Inhibitor; Tyrosine Kinase Inhibitor
Ingenol Mebutate
Picato
Topical Skin Product
Onfi
Clobazam
Benzodiazepine
November 2011
Ruxolitinib
Jakafi
Janus Associated Kinase Inhibitor
Bupivacaine (Liposomal)
Exparel
Analgesic, Nonopioid
October 2011
Deferiprone
Ferriprox
Chelating Agent
August 2011
Crizotinib
Xalkori
Antineoplastic Agent
Icatibant
Firazyr
Selective Bradykinin B2 Receptor Antagonist
Brentuximab Vedotin
Adcetris
Antineoplastic Agent, monoclonal antibody
Vemurafenib
Zelboraf
Antineoplastic Agent, BRAF Kinase Inhibitor
June 2011
Ezogabine
Potiga
Anticonvulsant
Belatacept
Nulojix
Selective T-Cell Costimulation Blocker
Fidaxomicin
Dificid
Macrolide antibiotic
May 2011
Boceprevir
Victrelis
Antiviral Agent, Protease Inhibitor
Telaprevir
Incivek
Antiviral Agent, Protease Inhibitor
Rilpivirine
Edurant
Antiretroviral agent, NNRTI
Linagliptin
Tradjenta
DPP-IV Inhibitor
Abiraterone
Zytiga
Antiandrogen
April 2011
Ipilimumab
Yervoy
Antineoplastic Agent
Vandetanib
Vandetanib
Antineoplastic Agent
Gabapentin Enacarbil
Horizant
Anticonvulsant, Miscellaneous
March 2011
Adenovirus (Types 4,7) Vaccine
None
Vaccine
Belimumab
Benlysta
Monoclonal Antibody
New Drug Combinations
Generic
Brand
Pharmacologic Category
October 2011
Juvisync
Sitagliptin and Simvastatin
DPP-IV Inhibitor/HMG-CoA Reductase Inhibitor
August 2011
Emtricitabine, rilpivirine and tenofovir
Complera
Antiretroviral agent, combination
April 2011
Ibuprofen and Famotidine
Duexis
NSAID/H2 Antagonist
